Free shipping on all orders over $ 500

PD 169316

Cat. No. M2583

All AbMole products are for research use only, cannot be used for human consumption.

PD 169316 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
1mg USD 25 In stock
5mg USD 50 In stock
10mg USD 80 In stock
50mg USD 230 In stock
100mg USD 365 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PD 169316 is a cell-permeable, potent and selective p38 MAP kinase inhibitor that indirectly activates proteasome activity and has antiviral activity against Enterovirus71 with an IC50 value of 89 nM. PD169316 selectively inhibits the kinase activity of the phosphorylated p38 without hindering upstream kinases to phosphorylate p38. PD169316 shows antiviral activity against Enterovirus71. PD169316 shows antiviral activity against Enterovirus71. PD169316 (10 μM) inhibits TGFβ and Activin A, but not BMP4 signaling in CaOV3 cells. PD169316 (0.2-20 μM) inhibits TGFβ-induced Smad2 nuclear translocation, Smad7 mRNA induction, and reporter gene activity in CaOV3 cells. PD169316 (10 μM) shows a significantly increased rate of proliferation in Nestin knockdown cells, and can rescue the effect of Nestin knockdown on cell viability in the absence of EGF.

Customer Product Validations & Biological Datas
Source Oncol Lett (2018). Figure 7. PD169316
Method CCK‑8 assay
Cell Lines NB4 cells
Concentrations 10 μM
Incubation Time 24 h
Results The results of the CCK‑8 assay showed that PD169316 could partially reverse the growth inhibition induced by lapatinib treatment.
Chemical Information
Molecular Weight 360.34
Formula C20H13FN4O2
CAS Number 152121-53-4
Solubility (25°C) DMSO 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Fu Y, et al. Biochem Biophys Res Commun. The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.

[2] Nath R, et al. Cell Mol Biol Lett. Inhibition of p38 kinase mimics survival signal-linked protection against apoptosis in rat cerebellar granule neurons.

Related p38 MAPK Products
Hesperetin

Hesperetin is a potent and broad-spectrum inhibitor against human UGT activity.

BIRB796

BIRB 796 (Doramapimod) is a protein kinase inhibitor of p38 MAPK with Kd of 100pM.

Adezmapimod

Adezmapimod (SB203580) is a P38 MAPK inhibitor with an IC50 of 0.3-0.5 μM, which is 10 times less selective than SAPK3(106T) and SAPK4(106T), and inhibits PKB phosphorylation with an IC50 of 3-5 μM.

SB 202190

SB 202190 is a highly selective, potent and cell permeable inhibitor of p38 MAP kinase with IC50 values of 50 and 100 nM inhibiting p38α and p38β, respectively.

PH-797804

PH-797804 is a highly selective and potent inhibitor of p38 MAP kinase with IC50 of 26 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: PD 169316 supplier, p38 MAPK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.